Literature DB >> 24231745

Zinc (II) complex with a cationic Schiff base ligand: synthesis, characterization, and biological studies.

Sze Koon Lee1, Kong Wai Tan2, Seik Weng Ng3, Kah Kooi Ooi4, Kok Pian Ang4, Md Akim Abdah4.   

Abstract

A cationic Schiff base ligand, TSB (L) and its Zn (II) complex (1) were synthesized and characterized by using CHN, (1)H-NMR, FT-IR, UV, LC-MS, and X-ray methods. Their ability to inhibit topoisomerase I, DNA cleavage activities, and cytotoxicity were studied. X-ray diffraction study shows that the mononuclear complex 1 is four coordinated with distorted tetrahedral geometry. The singly deprotonated Schiff base ligand L acts as a bidentate ON-donor ligand. Complexation of L increases the inhibitory strength on topoisomerase I activity. Complex 1 could fully inhibit topoisomerase I activity at 250 μM, while L did not show any inhibitory effect on topoisomerase I activity. In addition, L and complex 1 could cleave pBR322 DNA in a concentration and time dependent profile. Surprisingly, L has better DNA cleavage activity than complex 1. The cleavage of DNA by complex 1 is altered in the presence of hydrogen peroxide. Furthermore, L and complex 1 are mildly cytotoxic towards human ovarian cancer A2780 and hepatocellular carcinoma HepG2.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cytotoxicity; DNA cleavage; Schiff base; Topoisomerase I; Zinc

Mesh:

Substances:

Year:  2013        PMID: 24231745     DOI: 10.1016/j.saa.2013.10.084

Source DB:  PubMed          Journal:  Spectrochim Acta A Mol Biomol Spectrosc        ISSN: 1386-1425            Impact factor:   4.098


  1 in total

1.  Biologically Active Cu(II), Co(II), Ni(II) and Zn(II) Complexes of Pyrimidine Derivative Schiff Base: DNA Binding, Antioxidant, Antibacterial and In Vitro Anticancer Studies.

Authors:  Nagaraj Revathi; Murugesan Sankarganesh; Jegathalaprathaban Rajesh; Jeyaraj Dhaveethu Raja
Journal:  J Fluoresc       Date:  2017-05-24       Impact factor: 2.217

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.